deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT07407725

Clinical Outcome Assessment for AT & BCI

Development of a Clinical Outcome Assessment for Assistive Technologies and Brain-Computer-Interfaces

Sponsor: Neuralink Corp

Updated 1 time since 2026 Last updated: Feb 5, 2026 Started: Jan 8, 2026 Primary completion: Dec 31, 2026 Completion: Jun 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07407725, this NA trial focuses on ALS (Amyotrophic Lateral Sclerosis) and Spinal Cord Injury and remains actively recruiting participants. Sponsored by Neuralink Corp, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

1 version recorded
Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Neuralink Corp
  • Shirley Ryan AbilityLab
Data source: Shirley Ryan AbilityLab

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations